Ovation Science Inc. (OVATF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ovation Science Inc. (OVATF) with AI Score 61/100 (Hold). Ovation Science Inc. develops and commercializes topical and transdermal cannabis and hemp products. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026Ovation Science Inc. (OVATF) Healthcare & Pipeline Overview
Ovation Science Inc. focuses on developing and marketing cannabis and hemp-based topical products using its patented Invisicare drug delivery technology. With operations in Canada, the United States, and Mexico, the company targets the health and wellness market through its Ovation and BASKiN brands, differentiating itself through innovative delivery systems.
Investment Thesis
Ovation Science Inc. presents a focused investment opportunity within the cannabis and hemp-based topical product market. The company's patented Invisicare technology provides a competitive edge in delivering cannabinoid-infused solutions. Key value drivers include expanding market penetration in Canada, the United States, and Mexico, along with the potential for new product development and licensing agreements. A gross margin of 81.5% indicates strong pricing power. However, the company's negative profit margin of -651.1% and limited market capitalization pose significant risks. Successful execution of its growth strategies and achieving profitability are critical for long-term value creation. Upcoming catalysts include potential regulatory changes in the cannabis industry and expansion into new geographic markets.
Based on FMP financials and quantitative analysis
Key Highlights
- Patented Invisicare technology offers a unique drug delivery system for topical cannabis and hemp products.
- Gross margin of 81.5% demonstrates strong potential for profitability if sales volume increases.
- Operations in Canada, the United States, and Mexico provide access to key cannabis markets.
- Diverse product portfolio includes health and wellness, skincare, and sanitization products.
- Market Cap of $0.00B indicates the company is a microcap stock with high growth potential but also high risk.
Competitors & Peers
Strengths
- Patented Invisicare drug delivery technology
- Established brands in key markets
- Diverse product portfolio
- Experienced management team
Weaknesses
- Negative profit margin
- Limited market capitalization
- Dependence on regulatory approvals
- Intense competition
Catalysts
- Upcoming: Potential regulatory changes in the cannabis industry could expand market access.
- Ongoing: Expansion into new geographic markets will drive revenue growth.
- Ongoing: Strategic partnerships and licensing agreements can increase market reach.
- Upcoming: New product development and launches will enhance product portfolio.
- Ongoing: Increased brand awareness and marketing efforts will drive sales.
Risks
- Potential: Changing regulatory landscape could negatively impact operations.
- Ongoing: Increased competition in the cannabis market could erode market share.
- Potential: Product liability risks associated with cannabis products.
- Potential: Economic downturn could reduce consumer spending on discretionary items.
- Ongoing: Dependence on regulatory approvals for new products and markets.
Growth Opportunities
- Expansion into New Therapeutic Areas: Ovation Science can leverage its Invisicare technology to develop topical products targeting specific therapeutic areas such as pain management, dermatology, and wound healing. The global market for topical pain relief products is projected to reach $15.7 billion by 2027, presenting a significant opportunity for Ovation Science to expand its product offerings and capture market share. Timeline: 2-3 years.
- Geographic Expansion: The company can further expand its presence in existing markets and enter new geographic regions where cannabis and hemp products are legal. The European cannabis market is projected to reach €3.2 billion by 2025, offering a substantial growth opportunity for Ovation Science to establish a foothold in this emerging market. Timeline: Ongoing.
- Strategic Partnerships and Licensing Agreements: Ovation Science can pursue strategic partnerships with established pharmaceutical companies, retailers, and distributors to expand its market reach and access new customer segments. Licensing its Invisicare technology to other companies can also generate revenue and increase brand awareness. Timeline: Ongoing.
- New Product Development: The company can invest in research and development to create new and innovative cannabis and hemp-based products that address unmet needs in the market. This includes exploring new delivery methods, formulations, and ingredients to enhance product efficacy and appeal. Timeline: 1-2 years.
- Increased Brand Awareness and Marketing Efforts: Ovation Science can invest in marketing and advertising campaigns to increase brand awareness and drive sales of its products. This includes leveraging social media, influencer marketing, and public relations to reach target audiences and promote the benefits of its products. Timeline: Ongoing.
Opportunities
- Expansion into new therapeutic areas
- Geographic expansion into new markets
- Strategic partnerships and licensing agreements
- New product development
Threats
- Changing regulatory landscape
- Increased competition
- Product liability risks
- Economic downturn
Competitive Advantages
- Patented Invisicare drug delivery technology provides a competitive advantage.
- Established brands and distribution channels in key markets.
- Focus on innovation and product development.
- Expertise in cannabis and hemp product formulation and manufacturing.
About OVATF
Ovation Science Inc., established in 2017 and headquartered in Vancouver, Canada, specializes in the creation and distribution of cannabis and hemp-based products. The company's core technology, Invisicare, is a patented drug delivery system designed for topical and transdermal applications. This technology is central to the development of skincare and wellness products infused with hemp seed oil and cannabis. Ovation Science markets its products under several brands, including Ovation and BASKiN, which offer a range of topical solutions. Additionally, the company provides cannabidiol-infused health and wellness products under the Invibe MD brand, skincare solutions under the ARLO CBD name, and hand sanitizers under the DermSafe brand. Ovation Science operates in Canada, the United States, and Mexico, holding sublicenses for cannabis-based products and the Lighthouse brand for licensed dispensaries in the United States. The company aims to leverage its innovative technology and diverse product portfolio to capture a significant share of the growing cannabis and hemp market.
What They Do
- Develops and commercializes topical cannabis and hemp products.
- Utilizes patented Invisicare drug delivery technology.
- Offers cannabidiol-infused health and wellness solutions.
- Provides skincare solutions under the ARLO CBD brand.
- Markets hand sanitizers under the DermSafe name.
- Holds sublicenses for cannabis-based products.
- Operates in Canada, the United States, and Mexico.
Business Model
- Develops and manufactures cannabis and hemp-based topical products.
- Markets and sells products through its own brands and distribution channels.
- Generates revenue through product sales and licensing agreements.
- Focuses on innovation and product development to maintain a competitive edge.
Industry Context
Ovation Science Inc. operates within the rapidly expanding cannabis and hemp industry, which is experiencing significant growth due to increasing legalization and acceptance of cannabis-based products for medicinal and recreational use. The market is characterized by intense competition, with numerous companies vying for market share in various segments, including topicals, edibles, and beverages. Ovation Science's focus on topical applications and its patented Invisicare technology position it to capitalize on the growing demand for innovative and effective cannabis-infused products. The company faces competition from both established pharmaceutical companies and emerging cannabis startups.
Key Customers
- Consumers seeking topical cannabis and hemp products for health and wellness.
- Patients seeking relief from pain, inflammation, and other conditions.
- Retailers and dispensaries that sell cannabis and hemp products.
- Companies that license Ovation Science's Invisicare technology.
Financials
Chart & Info
Ovation Science Inc. (OVATF) stock price: Price data unavailable
Latest News
No recent news available for OVATF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for OVATF.
Price Targets
Wall Street price target analysis for OVATF.
MoonshotScore
What does this score mean?
The MoonshotScore rates OVATF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Terry H. Howlett
CEO
Terry H. Howlett serves as the CEO of Ovation Science Inc. His background includes extensive experience in the pharmaceutical and healthcare industries. Prior to joining Ovation Science, he held leadership positions at various companies, focusing on product development, marketing, and sales. His expertise spans across multiple therapeutic areas, including dermatology and pain management. Howlett's experience in bringing innovative products to market is expected to drive Ovation Science's growth strategy.
Track Record: Under Terry Howlett's leadership, Ovation Science has focused on expanding its product portfolio and market reach. Key milestones include the development and launch of new cannabis and hemp-based topical products, as well as the establishment of strategic partnerships to expand distribution channels. Howlett's strategic decisions have been instrumental in positioning Ovation Science as a leader in the cannabis topical market.
OVATF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Ovation Science Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements, which can increase investment risk.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases investment risk.
- Low trading volume and wide bid-ask spreads can lead to price volatility.
- Fewer regulatory requirements compared to major exchanges.
- Potential for fraud or manipulation.
- Higher risk of delisting or going out of business.
- Verify the company's financial statements and disclosures.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Understand the risks associated with investing in OTC stocks.
- Patented Invisicare technology.
- Operations in Canada, the United States, and Mexico.
- Experienced management team.
- Presence of established brands.
Common Questions About OVATF
What does Ovation Science Inc. do?
Ovation Science Inc. is a healthcare company focused on developing and commercializing topical cannabis and hemp products. The company utilizes its patented Invisicare drug delivery technology to create and market a range of cannabinoid-infused health and wellness solutions. These products are sold under various brands, including Ovation, BASKiN, Invibe MD, ARLO CBD, and DermSafe. Ovation Science operates in Canada, the United States, and Mexico, targeting consumers seeking topical cannabis and hemp products for various health and wellness applications.
What do analysts say about OVATF stock?
AI analysis is pending for OVATF stock. Generally, microcap stocks like Ovation Science Inc. are subject to limited analyst coverage. Investors should conduct their own due diligence and consider the company's financial performance, growth prospects, and risk factors before making any investment decisions. Key valuation metrics to consider include revenue growth, gross margin, and profitability. Growth considerations include expansion into new markets, new product development, and strategic partnerships.
What are the main risks for OVATF?
Ovation Science Inc. faces several risks, including regulatory uncertainty in the cannabis industry, intense competition from other cannabis companies, product liability risks associated with cannabis products, and dependence on regulatory approvals for new products and markets. The company's negative profit margin and limited market capitalization also pose significant financial risks. Additionally, economic downturns could reduce consumer spending on discretionary items, impacting sales of Ovation Science's products.
What are the key growth opportunities for OVATF in healthcare?
Ovation Science Inc.'s key growth opportunities in healthcare lie in expanding its product offerings into new therapeutic areas, such as pain management, dermatology, and wound healing. The company can also leverage its Invisicare technology to develop innovative delivery methods and formulations. Geographic expansion into new markets, particularly in Europe and Latin America, presents another significant growth opportunity. Strategic partnerships with established pharmaceutical companies and retailers can also accelerate market penetration and increase brand awareness.
How does Ovation Science Inc. manage patent expiration risks?
As Ovation Science Inc. relies on its patented Invisicare technology, managing patent expiration risks is crucial. The company can mitigate these risks by continuously investing in research and development to create new and innovative technologies and products. Filing new patent applications to extend patent protection and diversifying its product portfolio to reduce dependence on a single technology are also important strategies. Additionally, Ovation Science can explore licensing agreements and strategic partnerships to leverage its technology and generate revenue beyond its own product sales.
What are the key factors to evaluate for OVATF?
Ovation Science Inc. (OVATF) currently holds an AI score of 61/100, indicating moderate score. Key strength: Patented Invisicare drug delivery technology. Primary risk to monitor: Potential: Changing regulatory landscape could negatively impact operations.. This is not financial advice.
How frequently does OVATF data refresh on this page?
OVATF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven OVATF's recent stock price performance?
Recent price movement in Ovation Science Inc. (OVATF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Patented Invisicare drug delivery technology. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited due to OTC status.
- AI analysis is pending.